Sho Miyamoto

Tokyo, 2080011, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Study protocol for a phase II clinical trial evaluating the safety and efficacy of favipiravir injection combined with oseltamivir in influenza treatment.

Study protocol for a phase II clinical trial evaluating the safety and efficacy of favipiravir injection combined with oseltamivir in influenza treatment.

Journal: BMJ open

Published: August 26, 2026

Emerging Multi-Source Transmission of SFTS Virus on a Remote Japanese Island: A One-Health Perspective.

Emerging Multi-Source Transmission of SFTS Virus on a Remote Japanese Island: A One-Health Perspective.

Journal: International journal of molecular sciences

Published: January 03, 2026

Longitudinal antibody titers measured after COVID-19 mRNA vaccination can identify individuals at risk for subsequent infection.

Longitudinal antibody titers measured after COVID-19 mRNA vaccination can identify individuals at risk for subsequent infection.

Journal: Science translational medicine

Published: September 17, 2025

Influenza A virus circumvents the innate immune response through the sequestration of double-stranded RNA.

Influenza A virus circumvents the innate immune response through the sequestration of double-stranded RNA.

Journal: Journal of virology

Published: September 08, 2025

Fulminant Viral Myocarditis Associated with Thogotovirus.

Fulminant Viral Myocarditis Associated with Thogotovirus.

Journal: The New England journal of medicine

Published: September 03, 2025

What Drives Respondents to Seroepidemiological Surveys? Insights From COVID-19 and Implications for Future Pandemics.

What Drives Respondents to Seroepidemiological Surveys? Insights From COVID-19 and Implications for Future Pandemics.

Journal: Journal of epidemiology

Published: August 03, 2025

Iguratimod, a promising therapeutic agent for COVID-19 that attenuates excessive inflammation in mouse models.

Iguratimod, a promising therapeutic agent for COVID-19 that attenuates excessive inflammation in mouse models.

Journal: European journal of pharmacology

Published: November 27, 2024

Duration of infectious virus shedding of SARS-CoV-2 Omicron variant among immunocompromised patients.

Duration of infectious virus shedding of SARS-CoV-2 Omicron variant among immunocompromised patients.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: October 05, 2024

Serum anti-nucleocapsid antibody correlates of protection from SARS-CoV-2 re-infection regardless of symptoms or immune history.

Serum anti-nucleocapsid antibody correlates of protection from SARS-CoV-2 re-infection regardless of symptoms or immune history.

Journal: Communications medicine

Published: July 05, 2024

Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence, Japan, 2023.

Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence, Japan, 2023.

Journal: Emerging infectious diseases

Published: May 23, 2024

Interpreting the Influence of Using Blood Donor Residual Samples for SARS-CoV-2 Seroprevalence Studies in Japan: Cross-Sectional Survey Study.

Interpreting the Influence of Using Blood Donor Residual Samples for SARS-CoV-2 Seroprevalence Studies in Japan: Cross-Sectional Survey Study.

Journal: JMIR public health and surveillance

Published: May 15, 2024

Necroptosis in alveolar epithelial cells drives lung inflammation and injury caused by SARS-CoV-2 infection.

Necroptosis in alveolar epithelial cells drives lung inflammation and injury caused by SARS-CoV-2 infection.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: March 11, 2024

Showing 1-12 of 35

Last Updated: 09/26/2026